Share this article on:

Antiviral treatments over cell-to-cell infection: is it just a matter of dose?*

Moris, Arnauda,b

doi: 10.1097/01.aids.0000432447.45486.03
Editorial Comment

aINSERM UMRS-945, UPMC Univ Paris 06

bAP-HP, Département d’Immunologie, Hôpital Pitié-Salpêtrière, Paris, France.

Correspondence to Arnaud Moris, PhD, INSERM UMRS-945, UPMC Univ Paris 06, 91 Bd de l’Hôpital, 75013, Paris, France. E-mail:

*See the original article by Duncan et al. in issue 27.14 on pages 2201–2206.

Received 29 May, 2013

Accepted 11 June, 2013

© 2013 Lippincott Williams & Wilkins, Inc.